INTRODUCTION
Acute cholecystitis is a disease commonly treated in secondary health care institutions. 1, 2 Cholecystectomy is the and safe treatment modality. [3] [4] [5] [6] However, patients with poor physical status often cannot undergo surgery on admission because of problems such as severe sepsis, extreme old age, and comorbidities. Although cholecystectomy is generally safe, the mortality rate of cholecystectomy in patients with high surgical risk, especially the elderly or critically ill, has been reported between 14% and 30%. [7] [8] [9] Ultrasonography-guided transhepatic percutaneous cholecystostomy (PC) is a minimally invasive, image-guided intervention performed under local anesthesia. Therefore, it has become a useful therapeutic intervention in elderly or critically ill patients. 10, 11 However, it has been considered as a bridging modality for high-risk surgical patients until surgical treatment, cholecystectomy. 12, 13 It remains controversial whether this procedure should only be used as a temporary measure to delay definitive cholecystectomy or if this procedure can be a definitive treatment.
The aim of this study was to determine if PC is appropriate as definitive treatment for acute cholecystitis in patients with high surgical risks, using a well-designed management protocol.
SUBJECTS AND METHODS

Study population
All patients who were admitted to Cheju Halla General Hospital (Jeju, Korea) via the emergency center or outpatient clinic with acute cholecystitis and who underwent ultra- No published guidelines regarding tube removal were available to follow when this study began. Therefore, we cre- 
Statistics
Descriptive statistics, including continuous and categorical variables, were given as mean±SD, frequencies, and percents. To compare the variables between groups, Student's t-test was used for continuous variables and chi-square test for categoricals. Values of p＜0.05 were accepted as significant. The overall survival of each treatment group was analyzed using Kaplan-Meier methods, and study groups were compared with the use of the log rank test. The hazard ratio was estimated using a stratified Cox proportional hazard model. All the statistical analyses were carried out using SPSS software version 15.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
A total 82 subjects that underwent ultrasound-guided PC were enrolled in this study. Listed comorbidities are shown in Table 1 . Baseline characteristics of the enrolled patients and the two groups are described in Table 2 .
The technical success rate for PC was 100%, and the clin- shown in Table 2 . There were no statistical differences between the 2 groups in age, sex, proportion of gallstone disease, organ dysfunction, initial laboratory results, or mean follow-up duration. Higher classes of ASA physical status and ECOG scores were observed for patients in the BSC group than for patients in the cholecystectomy group (p＜0.001).
Additionally, the BSC group had more patients who needed ICU care (p＜0.001).
During the median 5.2 months of observation, median survival times were recorded to be 2.4 months for the BSC group, 15.3 for the cholecystectomy group, and 4.4 overall (p=0.001, Fig. 3 ).
We separated all patients' based on ASA class and ECOG scores into 2 groups (higher group and lower group). When we did this, we found no significant difference in survival rates between the cholecystectomy group and BSC group in the Kaplan-Meier survival analysis. In the multivariate analysis of survival based on the Cox proportional hazard model using log-rank test, age and ASA class were significantly correlated with survival (Table 3) . However, the survival difference between the cholecystectomy and BSC groups did not reach statistical significance (Table 4) .
Clinical outcomes of the 2 BSC subgroup: removed and maintained
Among the 47 patients in the BSC group, the drainage tube was removed in 31 (75.6%) and maintained in 16 (34.0%), according to the protocol described above. The baseline characteristics and clinical outcomes of the 2 subgroups within the BSC group are described in Table 4 .
Between the 2 BSA subgroups, ASA class, ECOG performance score, proportion of the gallstones, and incidence of organ failure (such as shock or renal failure) did not differ.
Median survival times were 6.9 months in the BSC group, 3.2 in the maintained group, and 7.9 in the removed group 
DISCUSSION
Elective cholecystectomy after cholecystostomy is the optimal treatment for acute calculous or acalculous cholecystitis.
However, in patients with considerable surgical risks, cholecystectomy under general anesthesia can cause serious morbidity and mortality. 17, 18 Therefore, this study assessed if PC is appropriate as a definitive treatment for acute cholecystitis in patients with surgical risks.
Recent reports have demonstrated that PC is effective as a definitive procedure without further cholecystectomy in certain populations. Some reports insisted that these patients should receive elective cholecystectomy because of the high rates of recurrent biliary complications after removal of cholecystostomy tubes (as high as 40%). [19] [20] [21] [22] In contrast, other studies have shown lower recurrence rates of biliary complications after removal of cholecystostomy tubes. These studies concluded, therefore, that PC could be a definite therapy without additive cholecystectomy. [23] [24] [25] [26] They reported the recurrence rates of biliary complications as 0-15%. Additionally, a randomized controlled trial showed that only 1 of 19 cases reported recurrent biliary complications, 17 and most recurrent cases improved with conservative medical treatment. 17, 24, 27 We demonstrate similar success and complication rates to previous studies using these procedures. We found no significant difference in survival rate between the 2 treatment groups (cholecystectomy vs. BSC) in surgical high-risk cases (ASA class ≥4, ECOG score ≥3). Rather, we found that old age and comorbidity state (ASA class) were more important predictors of better clinical outcomes via multivariate analysis.
Another important finding of this study is the non-recurrence of biliary complications, including cholecystitis, observed in 25 cases where cholecystostomy tubes were removed. In our study, no recurrent biliary complications occurred during an overall median follow-up of 7.1 months. This lower incidence of recurrence may be due to the tailored management of the cholecystostomy tubes according to our well-designed protocols. We performed cholecystograms to check the patency of the biliary trees in each of the 31 cholecystostomy cases, and then decided whether or not to remove their tubes. In previous studies, no detailed strategy for the management of cholecystostomy tubes was employed--they did not conduct cholangiograms before deciding to remove patients' cholecystostomy tubes, except in one case.
Our study has several limitations. First, this was a retrospective study and it contained a relatively small group size.
Second, the observation period of the BSC subgroups (maintained group and removed group) was relatively short.
In addition, the definition of biliary patency was not obvious on cholangiogram images. Therefore, validation of this management protocol in a well-designed, randomized, pro-
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In summary, we concluded that BSC with PC rather than cholecystectomy may be considered in cholecystitis patients with extreme old age and higher morbidity (ASA ≥4). It can be considered to recommend BSC rather than cholecystectomy.
